Cargando…

Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty Liver

The liver neutralizes endogenous and exogenous toxins and metabolites, being metabolically interconnected with many organs. Numerous clinical and experimental studies show a strong association between Non-alcoholic fatty liver disease (NAFLD) and loss of skeletal muscle mass known as sarcopenia. Liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Chiara, Francesco, Ferret-Miñana, Ainhoa, Fernández-Costa, Juan M., Senni, Alice, Jalan, Rajiv, Ramón-Azcón, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139027/ https://www.ncbi.nlm.nih.gov/pubmed/35625696 http://dx.doi.org/10.3390/biomedicines10050958

Ejemplares similares

Direct and Label-Free Monitoring of Albumin in 2D Fatty Liver Disease Model Using Plasmonic Nanogratings
por: Lopez-Muñoz, Gerardo A., et al.
Publicado: (2020)

The Synergy between Organ-on-a-Chip and Artificial Intelligence for the Study of NAFLD: From Basic Science to Clinical Research
por: De Chiara, Francesco, et al.
Publicado: (2021)

Disposable Polymeric Nanostructured Plasmonic Biosensors for Cell Culture Adhesion Monitoring
por: Vila, Judith Camaló, et al.
Publicado: (2021)

High Protein Diet and Metabolic Plasticity in Non-Alcoholic Fatty Liver Disease: Myths and Truths
por: De Chiara, Francesco, et al.
Publicado: (2019)

Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease
por: Lakhani, Hari Vishal, et al.
Publicado: (2018)

Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells
por: Lyall, Marcus J., et al.
Publicado: (2018)

Ammonium quantification in human plasma by proton nuclear magnetic resonance for staging of liver fibrosis in alcohol‐related liver disease and nonalcoholic fatty liver disease
por: Azagra, Marc, et al.
Publicado: (2022)

Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
por: Legaki, Aigli-Ioanna, et al.
Publicado: (2022)

Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
por: Pan, Xiaoli, et al.
Publicado: (2022)

The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
por: Dong, Yuan, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor
por: Takeichi, Yukina, et al.
Publicado: (2021)

Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease
por: Zhang, Yizhi, et al.
Publicado: (2022)

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
por: Wang, Huan, et al.
Publicado: (2023)

Albumin-fatty acid interactions at monolayer interface
por: Gew, Lai Ti, et al.
Publicado: (2014)

Serum albumin-fatty acid saturation test
por: Gonçalves-de-Albuquerque, Cassiano Felippe, et al.
Publicado: (2019)

Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease
por: Jia, Lin, et al.
Publicado: (2018)

Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease
por: Han, Mei, et al.
Publicado: (2020)

Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease in male mice
por: Weiss, Jonathan M., et al.
Publicado: (2023)

In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications
por: Ramos, Maria Jimenez, et al.
Publicado: (2021)

Giving combined medium‐chain fatty acids and glucose protects against cancer‐associated skeletal muscle atrophy
por: Mori, Takuya, et al.
Publicado: (2019)

Can apricot kernels fatty acids delay the atrophied hepatocytes from progression to fibrosis in dimethylnitrosamine (DMN)-induced liver injury in rats?
por: Abdel-Rahman, Manal K
Publicado: (2011)

New volumetric CNT-doped gelatin–cellulose scaffolds for skeletal muscle tissue engineering
por: Velasco-Mallorquí, Ferran, et al.
Publicado: (2020)

Bioengineered in vitro skeletal muscles as new tools for muscular dystrophies preclinical studies
por: Fernández-Costa, Juan M., et al.
Publicado: (2021)

Hepatocyte mARC1 promotes fatty liver disease
por: Lewis, Lara C., et al.
Publicado: (2023)

Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver
por: Kang, Min-Kyu, et al.
Publicado: (2021)

Association of Low Skeletal Muscle Mass with the Phenotype of Lean Non-Alcoholic Fatty Liver Disease
por: Byeon, Jun-Hyeon, et al.
Publicado: (2022)

Curcumol inhibits ferritinophagy to restrain hepatocyte senescence through YAP/NCOA4 in non‐alcoholic fatty liver disease
por: Qi, Xiaoyu, et al.
Publicado: (2021)

PFOA Exposure Prior to Hepatocyte Differentiation Leads to Gene Expression Changes Implicated in Non-Alcoholic Fatty Liver Disease
por: Hanke, Stephanie, et al.
Publicado: (2021)

Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease
por: Xu, Yanyong, et al.
Publicado: (2021)

Lonicera caerulea Extract Attenuates Non-Alcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Hepatocytes and in High Fat Diet-Fed Mice
por: Park, Miey, et al.
Publicado: (2019)

CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease
por: Wang, Yinhan, et al.
Publicado: (2023)

Irisin Ameliorated Skeletal Muscle Atrophy by Inhibiting Fatty Acid Oxidation and Pyroptosis Induced by Palmitic Acid in Chronic Kidney Disease
por: Zhou, Ting, et al.
Publicado: (2023)

High production of fatty alcohols in Escherichia coli with fatty acid starvation
por: Liu, Yilan, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy
por: Guber, Robert D., et al.
Publicado: (2017)

Resveratrol Modulates Desaturase Expression and Fatty Acid Composition of Cultured Hepatocytes
por: Kühn, Gianna, et al.
Publicado: (2018)

Fatty Liver Index and Skeletal Muscle Density
por: Pasco, Julie A., et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease
por: Breher-Esch, Stephanie, et al.
Publicado: (2018)

LncRNA MAYA promotes iron overload and hepatocyte senescence through inhibition of YAP in non‐alcoholic fatty liver disease
por: Yuan, Ping, et al.
Publicado: (2021)

miR204 potentially promotes non-alcoholic fatty liver disease by inhibition of cpt1a in mouse hepatocytes
por: Kim, Seonhee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_li2lcu5aurhr7mlf2ia9381jsb